chr9-127663343-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_003165.6(STXBP1):c.568C>T(p.Arg190Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R190Q) has been classified as Pathogenic.
Frequency
Consequence
NM_003165.6 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 4Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autism spectrum disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003165.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STXBP1 | NM_003165.6 | MANE Plus Clinical | c.568C>T | p.Arg190Trp | missense | Exon 7 of 20 | NP_003156.1 | ||
| STXBP1 | NM_001032221.6 | MANE Select | c.568C>T | p.Arg190Trp | missense | Exon 7 of 19 | NP_001027392.1 | ||
| STXBP1 | NM_001374306.2 | c.559C>T | p.Arg187Trp | missense | Exon 7 of 19 | NP_001361235.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STXBP1 | ENST00000373302.8 | TSL:1 MANE Plus Clinical | c.568C>T | p.Arg190Trp | missense | Exon 7 of 20 | ENSP00000362399.3 | ||
| STXBP1 | ENST00000373299.5 | TSL:1 MANE Select | c.568C>T | p.Arg190Trp | missense | Exon 7 of 19 | ENSP00000362396.2 | ||
| STXBP1 | ENST00000494254.4 | TSL:5 | c.568C>T | p.Arg190Trp | missense | Exon 7 of 19 | ENSP00000485397.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727216
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 4 Pathogenic:4Other:1
PM6_Strong, PM5, PM2, PP2, PP3
The variant is not observed in the gnomAD v4.1.0 dataset. Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.90 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.99 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000207417 /PMID: 23708187). The variant has been previously reported as de novo in a similarly affected individual (PMID: 23934111). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 23708187, 23934111, 26514728, 26544041). The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least two similarly affected unrelated individuals (PMID: 23708187, 26514728, 26544041). A different missense change at the same codon (p.Arg190Gln) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000207418 /PMID: 26633542). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Pathogenic:2
STXBP1: PS2, PM2, PM5, PS4:Moderate, PP2, PP3
Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23708187, 26544041, 31976320, 32929885, 23934111, 27905812, 26514728, 31130284, 31785789, 33004838)
Neurodevelopmental delay Pathogenic:1
Developmental and epileptic encephalopathy Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 190 of the STXBP1 protein (p.Arg190Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with STXBP1-related conditions (PMID: 23708187, 23934111, 26514728, 26544041). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 207417). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt STXBP1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
Infantile epilepsy syndrome Pathogenic:1
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-02-09 and interpreted as Pathogenic. The reporting laboratory might also submit to ClinVar. This variant was identified in multiple probands enrolled in Simons Searchlight.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at